Quantification of circulating cell-free DNA to predict patient survival in non-small-cell lung cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hyun, Myung Han | - |
dc.contributor.author | Sung, Jae Sook | - |
dc.contributor.author | Kang, Eun Joo | - |
dc.contributor.author | Choi, Yoon Ji | - |
dc.contributor.author | Park, Kyong Hwa | - |
dc.contributor.author | Shin, Sang Won | - |
dc.contributor.author | Lee, Sung Yong | - |
dc.contributor.author | Kim, Yeul Hong | - |
dc.date.accessioned | 2021-09-02T23:07:04Z | - |
dc.date.available | 2021-09-02T23:07:04Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2017-11-07 | - |
dc.identifier.issn | 1949-2553 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/81573 | - |
dc.description.abstract | We used computed tomography (CT) to explore the prognostic value of cell-free (cf) DNA quantification and its predictive efficacy over time after chemotherapy in non-small-cell lung cancer (NSCLC) patients. In total, 177 NSCLC patients were enrolled in a prospective biomarker trial. Consecutive paired blood collection was performed to determine cfDNA concentrations at baseline CT and throughout serial follow-ups. The best cfDNA cut-off value to predict progression-free and overall survival was determined using X-tile analysis. Among 112 chemo-naive patients with stage IV adenocarcinoma, 43 were available for follow-up analysis. Cox regression multivariate analysis indicated that a high cfDNA concentration was an independent negative prognostic factor for progression-free survival (hazard ratio: 2.60; 95% confidence interval: 1.65-4.10; p = 0.008) and overall survival (hazard ratio: 2.63; 95% confidence interval: 1.66-4.17; p < 0.001). However, cfDNA concentration changes during treatment did not correlate with radiological CT responses at first follow-up or best response. No pattern was noted in the percent change in the cfDNA concentration from baseline or subsequently measured level to progression. The serum cfDNA concentration is thus associated with NSCLC patient prognosis, but does not appear to be a clinically valid marker for tumor responses. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | IMPACT JOURNALS LLC | - |
dc.subject | PLASMA DNA | - |
dc.subject | TUMOR DNA | - |
dc.subject | NUCLEIC-ACIDS | - |
dc.subject | BIOMARKER | - |
dc.subject | THERAPY | - |
dc.subject | CHEMOTHERAPY | - |
dc.subject | ORIGIN | - |
dc.subject | METAANALYSIS | - |
dc.subject | MARKER | - |
dc.subject | IMPACT | - |
dc.title | Quantification of circulating cell-free DNA to predict patient survival in non-small-cell lung cancer | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Sung, Jae Sook | - |
dc.contributor.affiliatedAuthor | Kang, Eun Joo | - |
dc.contributor.affiliatedAuthor | Choi, Yoon Ji | - |
dc.contributor.affiliatedAuthor | Park, Kyong Hwa | - |
dc.contributor.affiliatedAuthor | Kim, Yeul Hong | - |
dc.identifier.doi | 10.18632/oncotarget.21769 | - |
dc.identifier.scopusid | 2-s2.0-85032983818 | - |
dc.identifier.wosid | 000414608400099 | - |
dc.identifier.bibliographicCitation | ONCOTARGET, v.8, no.55, pp.94417 - 94430 | - |
dc.relation.isPartOf | ONCOTARGET | - |
dc.citation.title | ONCOTARGET | - |
dc.citation.volume | 8 | - |
dc.citation.number | 55 | - |
dc.citation.startPage | 94417 | - |
dc.citation.endPage | 94430 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.subject.keywordPlus | PLASMA DNA | - |
dc.subject.keywordPlus | TUMOR DNA | - |
dc.subject.keywordPlus | NUCLEIC-ACIDS | - |
dc.subject.keywordPlus | BIOMARKER | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | CHEMOTHERAPY | - |
dc.subject.keywordPlus | ORIGIN | - |
dc.subject.keywordPlus | METAANALYSIS | - |
dc.subject.keywordPlus | MARKER | - |
dc.subject.keywordPlus | IMPACT | - |
dc.subject.keywordAuthor | cell-free DNA concentration | - |
dc.subject.keywordAuthor | prognostic value | - |
dc.subject.keywordAuthor | non-small-cell lung cancer | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.